Impact of drugs with anti-inflammatory effects on skeletal muscle and inflammation: A systematic literature review
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Ageing-related low-grade inflammation is suggested to aggravate sarcopenia and frailty. This systematic review investigates the influence that drugs with anti-inflammatory effects (AIDs) have on inflammation and skeletal muscle. METHODS: PubMed and Web of Science were systematically screened for articles reporting the effects of AIDs on inflammation on one hand and on muscle mass and/or performance on the other. RESULTS: Twenty-eight articles were included. These articles were heterogeneous in terms of the subjects studied, intervention components, setting, and outcome measures. Articles on older humans with acute inflammation showed evidence that celecoxib and piroxicam could reduce inflammation and improve performance and that ibuprofen improves exercise-induced muscle hypertrophy and gains in strength. In younger humans, only the effects of AIDs combined with exercise were investigated; no significant benefits of non-selective COX-inhibitors were reported, but improved strength gains with etanercept and reduced muscle soreness with celecoxib were noted. Indomethacin increased acute exercise-induced inflammation and reduced satellite cell differentiation in exercising muscle. Most articles did not systematically report occurrences of side effects. CONCLUSIONS: Although AIDs showed significant reduction in inflammation-induced muscle weakness in older hospitalised patients with acute inflammation, robust evidence is still lacking. When combined with exercise, AIDs presented a protective effect against age-related loss of muscle mass, thus enhancing muscle mass and performance. The mechanism regulating muscle strength and its mass seems to differ between individuals of old and young age. However, the effects seem drug-specific and dose-dependent and appear to be influenced by subjects' trainability and the clinical context. In addition, the balance between benefits and harm remains unclear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zuniga, C., Arai, H., Boirie, Y., Chen, L.-K., Fielding, R. A., Martin, F. C., Michel, J.-P., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu115 · Cited by 1,963
Invited Review: Aging and sarcopenia
Doherty, T. J. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00347.2003 · Cited by 1,764 · cited 1×
“In rodent models, Domínguez-Álvarez et al. (Domínguez-Álvarez et al., 2014) used young male rats (eight weeks old) to study the effect of infliximab on respiratory muscle function, inflammatory and regeneration markers, and muscle structure.”
High-Intensity Strength Training in Nonagenarians: Effects on Skeletal Muscle
Fiatarone, M. A. (1990) · JAMA · doi:10.1001/jama.1990.03440220053029 · Cited by 1,593
The healthcare costs of sarcopenia in the United States
Janssen, I., Shepard, D. S., Katzmarzyk, P. T., & Roubenoff, R. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52014.x · Cited by 1,546 · cited 1×
“Kietrys et al. (Kietrys et al., 2011) elucidated the exposure-response relationships between voluntary highforce repetitive tasks for upper limb, inflammation, and motor changes with work-related musculoskeletal disorders in young adult female Sprague-Dawley rats (14 weeks of age).”
Inflammatory mediators in the elderly
Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928
Resistance exercise for muscular strength in older adults: a meta-analysis
Peterson, M. D., Rhea, M. R., Sen, A., & Gordon, P. M. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.03.004 · Cited by 808 · cited 14×
“Several intrinsic phenomena related to the ageing process contribute to CLIP, including disturbances in immune functions (Kuek et al., 2007), an increase in adipose mass (Wellen and Hotamisligil, 2005), and an accumulation of Advanced Glycation End (AGE) products (Van Puyvelde et al., 2014).”
InfluentialStress-induced gastrointestinal barrier dysfunction and its inflammatory effects1
Lambert, G. P. (2009) · Journal of Animal Science · doi:10.2527/jas.2008-1339 · Cited by 529 · cited 1×
“The ultradistance race induced muscle inflammation due to muscle damage, oxidative stress, increased metabolic demands, and stress hormone release, as well as increased gastrointestinal permeability and endotoxemia (Lambert, 2009; Nieman et al., 2005).”
Chronic low-grade inflammation and age-related sarcopenia
Beyer, I., Mets, T., & Bautmans, I. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834dd297 · Cited by 400
Self-citationHan, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377
The many faces of tumor necrosis factor in stroke
Hallenbeck, J. M. (2002) · Nature Medicine · doi:10.1038/nm1202-1363 · Cited by 367
Onder, G., Penninx, B. W., Balkrishnan, R., Fried, L. P., Chaves, P. H., Williamson, J., Carter, C., Bari, M. D., Guralnik, J. M., & Pahor, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08024-8 · Cited by 339 · cited 1×
“However, the use of fosinopril could not confirm a beneficial effect on inflammation and physical performance that earlier observations had suggested (Bauer et al., 2008; Brull et al., 2002; Carter et al., 2004; Cohn et al., 2007; Onder et al., 2002; Sumukadas et al., 2008, 2007, 2006; Witham et al., 2008).”
Visser, M., & Schaap, L. A. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.03.006 · Cited by 320
Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis
Trappe, T. A., White, F., Lambert, C. P., Cesar, D., Hellerstein, M., & Evans, W. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00352.2001 · Cited by 293
Singh, N. A., Quine, S., Clemson, L. M., Williams, E. J., Williamson, D. A., Stavrinos, T. M., Grady, J. N., Perry, T. J., Lloyd, B. D., Smith, E. U. R., et al. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.08.005 · Cited by 274
Sumukadas, D., Witham, M. D., Struthers, A. D., & McMurdo, M. E. T. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061339 · Cited by 246
Yarasheski, K. E., Pak-Loduca, J., Hasten, D. L., Obert, K. A., Brown, M. B., & Sinacore, D. R. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e118 · Cited by 226
Mikkelsen, U. R., Langberg, H., Helmark, I. C., Skovgaard, D., Andersen, L. L., Kjær, M., & Mackey, A. L. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00707.2009 · Cited by 185 · cited 1×
“(Mikkelsen et al., 2009), significant differences in inflammatory parameters between groups were found after the exercise.”
Muscle damage is linked to cytokine changes following a 160-km race
Nieman, D. C., Dumke, C. L., Henson, D. A., McAnulty, S. R., Gross, S. J., & Lind, R. H. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.03.008 · Cited by 180 · cited 1×
“The ultradistance race induced muscle inflammation due to muscle damage, oxidative stress, increased metabolic demands, and stress hormone release, as well as increased gastrointestinal permeability and endotoxemia (Lambert, 2009; Nieman et al., 2005).”
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
Reginster, J.-Y., Cooper, C., Rizzoli, R., Kanis, J. A., Appelboom, G., Bautmans, I., Bischoff-Ferrari, H. A., Boers, M., Brandi, M. L., Bruyère, O., et al. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0517-y · Cited by 112
Self-citationIbuprofen and Acetaminophen: Effect on Muscle Inflammation after Eccentric Exercise
PETERSON, J. M., TRAPPE, T. A., MYLONA, E., WHITE, F., LAMBERT, C. P., EVANS, W. J., & PIZZA, F. X. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000069917.51742.98 · Cited by 85 · cited 1×
“As compared to the placebo, both drugs induced no significant change in muscle soreness and had no influence on muscle inflammatory cell concentrations (Peterson et al., 2003).”
Cesari, M., Pedone, C., Antonelli Incalzi, R., & Pahor, M. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2009.09.014 · Cited by 67
Cited by
Multisystem physiological perspective of human frailty and its modulation by physical activity
Taylor, J. A., Greenhaff, P. L., Bartlett, D. B., Jackson, T. A., Duggal, N. A., & Lord, J. M. (2023) · Physiological Reviews · doi:10.1152/physrev.00037.2021 · Cited by 197
Lipid metabolism in sarcopenia
Al Saedi, A., Debruin, D. A., Hayes, A., & Hamrick, M. (2022) · Bone · doi:10.1016/j.bone.2022.116539 · Cited by 140
Pharmacological blockade of TNFα prevents sarcopenia and prolongs survival in aging mice
Sciorati, C., Gamberale, R., Monno, A., Citterio, L., Lanzani, C., De Lorenzo, R., Ramirez, G. A., Esposito, A., Manunta, P., Manfredi, A. A., et al. (2020) · Aging · doi:10.18632/aging.202200 · Cited by 79
“Cyclooxygenase inhibitors improve mass and strength in older muscle when used in combination with resistance training programs [27].”
BackgroundEspinoza, S. E., Woods, R. L., Ekram, A. R. M. S., Ernst, M. E., Polekhina, G., Wolfe, R., Shah, R. C., Ward, S. A., Storey, E., Nelson, M. R., et al. (2022) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glab340 · Cited by 39
Metadata
- Authors
- Alturki, M., Beyer, I., Mets, T., & Bautmans, I.
- Venue
- Experimental Gerontology
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 114
- Pages
- 33-49
- ISSN
- 0531-5565 (ISSN-L)
- OpenAlex
- W2898341923
- Cited by
- 36
- References
- 21
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.